TABLE 6.
Implementation of Hib vaccine in countries of the WHO Western Pacific Regiona
| Country | Yr of introduction | NIP | Formulation in 2019 | Schedule in 2019 | Coverage of Hib3 in 2019 (%) | Yr in which coverage reached ≥50% |
|---|---|---|---|---|---|---|
| Australia | 1993 | Yes | DTaP/Hib/HepB/IPV | 2, 4, 6 mo | 95 | 1997 |
| Hib | 18 mo | |||||
| Brunei Darussalem | 2002 | Yes | DTaP/Hib/HepB/IPV | 2, 4, 6 mo | 99 | 2002 |
| Hib | 1 yr | |||||
| Cambodia | 2010 | Yes | DTwP/Hib/HepB | 6, 10, 14 wks | 92 | 2010 |
| China | No | |||||
| Cook Islands | 2009 | Yes | DTaP/Hib/HepB | 6 wks, 3, 5 mo | 98 | 2009 |
| Fiji | 1997 | Yes | DTwP/Hib/HepB | 6, 10, 14 wks | 99 | 1997 |
| Japan | 2011 | Yes | Hib | 2, 3, 4 mo, 1 yr | 98 | 2011 |
| Kiribati | 2008 | Yes | DTwP/Hib/HepB | 6, 10, 14 wks | 95 | 2008 |
| Lao People’s Democratic Republic | 2009 | Yes | DTwP/Hib/HepB | 6, 10, 14 wks | 68 | 2010 |
| Malaysia | 2002 | Yes | DTaP/Hib/HepB/IPV | 2, 3, 5, 18 mo | 98 | 2004 |
| The Marshall Islands | 1998 | Yes | DTaP/Hib/IPV | 2, 4, 12 mo | 72 | 2002 |
| Hib | 2, 4, 12 mo | |||||
| Federated States of Micronesia | 1996 | Yes | Hib | 2, 4, 12 mo | 64 | 2000 |
| Mongolia | 2005 | Yes | DTwP/Hib/HepB | 2, 3, 4 mo | 99 | 2006 |
| Nauru | 2009 | Yes | DTwP/Hib/HepB | 6, 10, 14 wks | 96 | 2009 |
| New Zealand | 1994 | Yes | DTaP/Hib/HepB/IPV | 6 wks, 3, 5 mo | 91 | 1997 |
| Hib | 15 mo | |||||
| Niue | 1998 | Yes | DTaP/Hib/HepB/IPV | 6 wks, 3, 5 mo | 99 | 2000 |
| Hib | 15 mo | |||||
| Palau | 1998 | Yes | Hib | 2, 4, 6 mo | 93 | 1998 |
| Papua New Guinea | 2008 | Yes | DTwP/Hib/HepB | 1, 2, 3 mo | 35 | 2009 |
| The Philippines | 2012 | Yes | DTwP/Hib/HepB | 6, 10, 14 wks | 65 | 2013 |
| The Republic of Korea | 2013 | Yes | DTaP/Hib/IPV | 2, 4, 6 mo | 98 | 2014 |
| Hib | 12–15 mo | |||||
| Samoa | 2007 | Yes | DTwP/Hib/HepB | 6, 10, 14 wks | 58 | 2009 |
| Singapore | 2013 | Yes | DTaP/Hib/IPV | 3, 4, 5, 18 mo | 96 | 2013 |
| Solomon Islands | 2008 | Yes | DTwP/Hib/HepB | 6, 10, 14 wks | 94 | 2008 |
| Tonga | 2005 | Yes | DTwP/Hib/HepB | 6, 10, 14 wks | 99 | 2005 |
| Tuvalu | 2009 | Yes | DTwP/Hib/HepB | 6, 10, 14 wks | 92 | 2009 |
| Vanuatu | 2011 | Yes | DTwP/Hib/HepB | 6, 10, 14 wks | 90 | 2011 |
| Vietnam | 2010 | Yes | DTwP/Hib/HepB | 2, 3, 4 mo | 89 | 2010 |
a
Annual birth cohort, 23.2 million. Children aged <5 years, 119.8 million. Twenty-four percent of target population was immunized with three doses of Hib (Hib3) in 2019 (based on WHO-UNICEF estimates) (168). NIP, national immunization program. Abbreviations of vaccine antigens: D, diphtheria; T, tetanus; aP, acellular pertussis; wP, whole-cell pertussis; Hib, Haemophilus influenzae type b; HepB, hepatitis B virus surface antigen; IPV, inactivated poliovirus.